Catalyst Capital Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
18,100
-1,100
| -6% | -$80.7K | 0.03% | 135 |
|
|
2025
Q1 | $2.19M | Buy |
+19,200
| New | +$2.19M | 0.04% | 108 |
|
|
2020
Q3 | – | Sell |
-160
| Closed | -$3K | – | 286 |
|
|
2020
Q2 | $3K | Hold |
160
| – | – | ﹤0.01% | 266 |
|
|
2020
Q1 | $2K | Sell |
160
-640
| -80% | -$8K | ﹤0.01% | 221 |
|
|
2019
Q4 | $10K | Hold |
800
| – | – | ﹤0.01% | 287 |
|
|
2019
Q3 | $11K | Hold |
800
| – | – | ﹤0.01% | 334 |
|
|
2019
Q2 | $9K | Sell |
800
-14,900
| -95% | -$168K | ﹤0.01% | 322 |
|
|
2019
Q1 | $184K | Sell |
15,700
-68,200
| -81% | -$799K | 0.01% | 199 |
|
|
2018
Q4 | $1.12M | Buy |
+83,900
| New | +$1.12M | 0.04% | 143 |
|
|
2018
Q2 | – | Sell |
-5,400
| Closed | -$89K | – | 455 |
|
|
2018
Q1 | $89K | Sell |
5,400
-62,500
| -92% | -$1.03M | ﹤0.01% | 263 |
|
|
2017
Q4 | $1.23M | Sell |
67,900
-4,250
| -6% | -$76.8K | 0.05% | 151 |
|
|
2017
Q3 | $1.39M | Buy |
72,150
+9,150
| +15% | +$177K | 0.06% | 143 |
|
|
2017
Q2 | $743K | Buy |
+63,000
| New | +$743K | 0.03% | 196 |
|
|
2014
Q4 | – | Sell |
-540,000
| Closed | -$1.45M | – | 496 |
|
|
2014
Q3 | $1.45M | Hold |
540,000
| – | – | 0.19% | 117 |
|
|
2014
Q2 | $1.51M | Buy |
+540,000
| New | +$1.51M | 0.25% | 114 |
|